UTMB is now the only institution in the Greater Houston Area—and one of only five in Texas—to be fully recognized by the Centers for Disease Control and Prevention (CDC) as a National Diabetes Prevention Program (DPP). More than 84 million U.S. adults have prediabetes, a condition where blood sugar is higher than normal but not high enough yet to be diagnosed as diabetes. People with prediabetes are at high risk for type 2 diabetes (the most common type of diabetes), heart disease and stroke, making this program particularly significant in improving health in our communities. Congratulations to the following UTMB team members for making the CDC full recognition a reality: Dr. Nicola Abate, professor and chief in the UTMB Division of Endocrinology; Dr. Hanaa Sallam, research scientist and coordinator of UTMB’s Diabetes Prevention Program; Michael Washburn, program manager of UTMB’s Angleton Danbury Campus Community Resources, Wellness and Volunteer Services; Dr. Raquel Pena, research scientist in the UTMB Department of Psychiatry and Behavioral Science; Dr. Ben Raimer, senior vice president, Office of Health Policy and Legislative Affairs; Dr. Michelle Sierpina, founding director, Osher Lifelong Learning Institute (OLLI); Dr. Cynthia Judice, chief medical officer for UTMB’s Primary Care Services and Community-Based Clinics; Dr. Hani Serag, research fellow in the Office of Health Policy and Legislative Affairs; Gene Felter, business manager for UTMB divisions of Cardiology and Endocrinology; Ann Varghese, director of Ambulatory Operations; and Julie Kuper, business coordinator in the Division of Endocrinology.